Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)

Q: What does CUSIP 74365A309 represent in this 13F holders report?

CUSIP 74365A309 is the security identifier for PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in Q4 2021?

24 institutional investors reported PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share for Q4 2021. Use the holders table for investor-level position and value details.

CUSIP: 74365A309

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 80,361,978
Total 13F shares: 2,921,778
Share change: -1,495,829
Total reported value: $2,436,675
Put/Call ratio: 106%
Price per share: $0.83
Number of holders: 24
Value change: -$1,654,962
Number of buys: 8
Number of sells: 19

Quarterly Holders Quick Answers

What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 74365A309:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Dexcel Pharma Technologies Ltd.	3/4/5	10%+ Owner	— class O/S missing	3,637,314	$5,128,613	—	02 Jun 2021	3/4/5
MORGAN STANLEY	13F	Company	2.8%	2,285,025	$3,039,000	—	30 Sep 2021	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.32%	254,871	$339,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.31%	251,171	$334,000	—	30 Sep 2021	13F
MEITAV INVESTMENT HOUSE LTD	13F	Company	0.3%	244,332	$325,000	—	30 Sep 2021	13F
Phoenix Financial Ltd.	13F	Company	0.3%	244,113	$325,000	—	30 Sep 2021	13F
GROUP ONE TRADING LLC	13F	Company	0.28%	222,553	$296,000	—	30 Sep 2021	13F
Walleye Capital LLC	13F	Company	0.27%	220,089	$293,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	0.15%	119,555	$159,000	—	30 Sep 2021	13F
SIMPLEX TRADING, LLC	13F	Company	0.09%	69,049	$129,000	—	30 Sep 2021	13F
Walleye Trading LLC	13F	Company	0.1%	81,000	$108,000	—	30 Sep 2021	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.07%	59,500	$79,000	—	30 Sep 2021	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	58,890	$78,000	—	30 Sep 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.05%	40,949	$54,000	—	30 Sep 2021	13F
DAVENPORT & Co LLC	13F	Company	0.04%	36,000	$48,000	—	30 Sep 2021	13F
IHT Wealth Management, LLC	13F	Company	0.04%	33,200	$44,000	—	30 Sep 2021	13F
CREDIT SUISSE AG/	13F	Company	0.04%	31,974	$43,000	—	30 Sep 2021	13F
WOLVERINE TRADING, LLC	13F	Company	0.04%	28,168	$39,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	24,945	$34,000	—	30 Sep 2021	13F
XTX Topco Ltd	13F	Company	0.03%	20,514	$27,000	—	30 Sep 2021	13F
Spire Wealth Management	13F	Company	0.02%	18,000	$24,000	—	30 Sep 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	14,200	$19,000	—	30 Sep 2021	13F
Cutler Group LLC / CA	13F	Company	0.01%	11,267	$14,000	—	30 Sep 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	8,890	$12,000	—	30 Sep 2021	13F
Psagot Value Holdings Ltd.	13F	Company	0.01%	6,000	$8,000	—	30 Sep 2021	13F
Psagot Value Holdings Ltd. / (Israel)	13F	Company	0.01%	6,000	$8,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	5,847	$8,000	—	30 Sep 2021	13F
FEDERATED HERMES, INC.	13F	Company	0.01%	5,761	$8,000	—	30 Sep 2021	13F
Migdal Insurance & Financial Holdings Ltd.	13F	Company	0%	4,000	$5,000	—	30 Sep 2021	13F
HARBOUR INVESTMENTS, INC.	13F	Company	0%	3,000	$4,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0%	2,194	$3,000	—	30 Sep 2021	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0%	1,100	$1,463	—	30 Sep 2021	13F
Steward Partners Investment Advisory, LLC	13F	Company	0%	1,000	$1,000	—	30 Sep 2021	13F
CAPTRUST FINANCIAL ADVISORS	13F	Company	0%	800	$1,000	—	30 Sep 2021	13F
Ten Capital Wealth Advisors, LLC	13F	Company	0%	552	$1,000	—	30 Sep 2021	13F
ROYAL BANK OF CANADA	13F	Company	0%	500	$1,000	—	30 Sep 2021	13F

Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q4 2021

As of 31 Dec 2021, Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,921,778 shares. The largest 10 holders included MORGAN STANLEY, GROUP ONE TRADING, L.P., Phoenix Holdings Ltd., Spire Wealth Management, BlackRock Inc., TWO SIGMA ADVISERS, LP, JANE STREET GROUP, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, and COMMONWEALTH EQUITY SERVICES, LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

-8

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.